{"schema_version":"secwatch.filing_event.v1","accession":"0001380106-25-000009","form_type":"8-K","ticker":"RPID","cik":"0001380106","company_name":"RAPID MICRO BIOSYSTEMS, INC.","filed_at":"2025-01-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.482046+00:00","generated_at":"2026-05-28T01:51:39.874594+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rapid Micro prelim Q4 rev record $8.2M, +30% YoY; Lonza collaboration","bullets":["Q4 total revenue preliminary ~$8.2M (record), +30% YoY; recurring rev ~$4.2M, +27% YoY.","FY 2024 total rev ~$28.1M, +25% YoY; recurring rev ~$15.5M, +14% YoY.","Placed 6 new Growth Direct systems in Q4; 21 systems placed in FY 2024; cumulative >160 placed globally.","Collaborated with Lonza to integrate Growth Direct with MODA-EM; Lonza deploying across global cell and gene therapy network.","Preliminary results unaudited; final results and 2025 outlook expected later in Q1 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001380106-25-000009","json":"https://secwatch.observer/filing/0001380106-25-000009.json","markdown":"https://secwatch.observer/filing/0001380106-25-000009.md","text":"https://secwatch.observer/filing/0001380106-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1380106/000138010625000009/0001380106-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1380106/000138010625000009/rpid-20250114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T01:51:39.874594+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}